Legislation

Title: Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
Sponsored by: Delegates Reznik and Valderrama
Status: In the House - Hearing 2/06 at 1:00 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to limit the cumulative amount a covered individual is required to pay on copayment or coinsurance for a covered prescription insulin drug to no more than $100, regardless of the amount or type of insulin needed to fill the covered individual's prescriptions; applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2021; etc.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Committee Testimony

Witness List

Details

Bill File Type: Regular

Effective Date(s): January 1, 2021

History

Legislation History
Chamber House Calendar Date 1/15/2020 Legislative Date 1/15/2020 Action First Reading Health and Government Operations Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance Proceedings
Chamber House Calendar Date 1/28/2020 Legislative Date 1/28/2020 Action Hearing 2/06 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	1/15/2020	1/15/2020	First Reading Health and Government Operations
			Text - First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
House	1/28/2020	1/28/2020	Hearing 2/06 at 1:00 p.m.

File Code

Subjects

Statutes